A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients

  • STATUS
    Recruiting
  • participants needed
    400
  • sponsor
    Covis Pharma S.à.r.l.
Send
Updated on 5 August 2020
See if I qualify
corticosteroids
fever
ciclesonide
dyspnea
cough
oximetry
covid-19
cystic fibrosis
chloroquine
SARS
hydroxychloroquine
pulmonary fibrosis
molecular diagnostic
acute respiratory syndrome (sars)
inhalation technique
alvesco

Summary

The purpose of this study is to assess the safety and efficacy of Alvesco (ciclesonide) Inhalation Aerosol in non hospitalized patients with symptomatic COVID-19 infection in a multicenter, randomized, double-blind, placebo controlled study

Details
Condition Covid 19
Age 12years - 100years
Treatment Placebo, Ciclesonide
Clinical Study IdentifierNCT04377711
SponsorCovis Pharma S.à.r.l.
Last Modified on5 August 2020

Eligibility

 Yes No Not Sure

Inclusion Criteria

b'Patients eligible for enrollment in the study must meet all the following criteria:'
b'Male and female adults and adolescents (12 years of age and above).'
b'Positive SARS-CoV-2 rapid molecular diagnostic test within 72 hours prior to'
b'enrollment.'
b'Patient is not currently hospitalized or under immediate consideration for'
b'hospitalization at the time of enrollment.'
b'Patient is currently experiencing symptoms of fever, cough, and/or dyspnea.'
b'Patient has an oxygen saturation level greater than 93%.'
b'Ability to show adequate use of MDI, including inhalation technique.'
b'Patient, parent/legal guardian, or legally-authorized representative must have signed'
b'a written informed consent before administration of any study-specific procedures.'

Exclusion Criteria

b'Patients meeting any of the following criteria are not eligible for participation in the'
b'tudy:'
b'Existence of any life-threatening co-morbidity or any other medical condition which,'
b'in the opinion of the investigator, makes the patient unsuitable for inclusion.'
b'History of hypersensitivity to ciclesonide.'
b'Treatment with inhaled or intranasal corticosteroids within 14 days of the screening/'
b'enrollment/randomization visit.'
b'Treatment with oral corticosteroids within 90 days of the'
b'creening/enrollment/randomization visit.'
b'Participation in any other clinical trial or use of any investigational agent within'
b'30 days of the screening/enrollment/randomization visit.'
b'Currently receiving treatment with hydroxychloroquine/chloroquine.'
b'Patients with cystic fibrosis.'
b'Patients with idiopathic pulmonary fibrosis.'
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

corticosteroids
fever
ciclesonide
dyspnea
cough
oximetry
covid-19
cystic fibrosis
chloroquine
SARS
hydroxychloroquine
pulmonary fibrosis
molecular diagnostic
acute respiratory syndrome (sars)
inhalation technique
alvesco

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.